1999
DOI: 10.1126/science.283.5410.2080
|View full text |Cite
|
Sign up to set email alerts
|

Requirement of Type III TGF-β Receptor for Endocardial Cell Transformation in the Heart

Abstract: Transforming growth factor-beta (TGF-beta) signaling is mediated by a complex of type I (TBRI) and type II (TBRII) receptors. The type III receptor (TBRIII) lacks a recognizable signaling domain and has no clearly defined role in TGF-beta signaling. Cardiac endothelial cells that undergo epithelial-mesenchymal transformation express TBRIII, and here TBRIII-specific antisera were found to inhibit mesenchyme formation and migration in atrioventricular cushion explants. Misexpression of TBRIII in nontransforming … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

12
243
0
6

Year Published

2000
2000
2006
2006

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 359 publications
(261 citation statements)
references
References 26 publications
(10 reference statements)
12
243
0
6
Order By: Relevance
“…This indicates that Sema6D affects the migration of both endothelial and mesenchymal cells from the CT segment and ventricle explants. This effect of Sema6D was in contrast to that of TGF-␤, which has been found to increase the mesenchymal cells from the CT segment (Brown et al 1999); TGF-␤ did not show a significant effect on the migration of endothelial cells from both explants ( Supplementary Fig. 3).…”
Section: Sema6d Displays Distinct Effects On Explants From Different mentioning
confidence: 79%
“…This indicates that Sema6D affects the migration of both endothelial and mesenchymal cells from the CT segment and ventricle explants. This effect of Sema6D was in contrast to that of TGF-␤, which has been found to increase the mesenchymal cells from the CT segment (Brown et al 1999); TGF-␤ did not show a significant effect on the migration of endothelial cells from both explants ( Supplementary Fig. 3).…”
Section: Sema6d Displays Distinct Effects On Explants From Different mentioning
confidence: 79%
“…The function of TGFBR3 is not fully clarified; however, evidence suggests that it supports the binding of TGF-to the TGFBR1-TGFBR2 complex, albeit that it lacks a recognizable signaling domain (Lopez-Cassilas et al 1993). Experimentally induced deficiency of TGFBR3 interfered with endocardial cell transformation in the heart, supporting its essential role in TGF-signaling (Brown et al 1999). In this report, we present 12 polymorphisms and some divergences from the published sequence found by sequencing the cDNA of TGFBR3 (n ϭ 6 Caucasian individuals), based on the known sequence of a 4208-bp fragment, consisting of an open reading frame (OFR) of 2547 bp (849 amino acids), flanked by a 5Ј untranslated region (UTR) of 348 bp and a 3Ј UTR of 1310 bp (Morén et al 1992; GenBank accession no., L07594).…”
Section: Introductionmentioning
confidence: 85%
“…TGFBR3 may also facilitate TGF-binding to other receptors, stabilize multimeric receptor complexes, or segregate growth factor from activating receptors (Ji et al 1999). In testing genetic defects of the TGF-III receptor gene, the present characterization of 12 polymorphisms may be useful for further linkage or association studies on potentially related phenotypes, including developmental defects of the heart (Brown et al 1999). …”
Section: Discussionmentioning
confidence: 99%
“…Both G-protein-mediated (Boyer et al, 1999b, Runyan et al, 1990 and TGF␤-mediated signal transduction processes were found to direct EMT (Brown et al, 1996(Brown et al, , 1999Potts et al, 1991Potts et al, , 1992. Within the chicken system, both TGF␤2 and ␤3 isoforms are necessary for the process in separate, sequential steps (Potts and Runyan, 1989;Potts et al, 1991;Runyan et al, 1992;Boyer et al, 1999a).…”
Section: Introductionmentioning
confidence: 99%